Clinical Trial Update: Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia

View source ↗

Summary

This document provides an update on a clinical trial evaluating cessation of tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• BOSULIF (bosutinib)
• Gleevec (Imatinib)
• Iclusig (ponatinib)
• Sprycel (dasatinib)
• Tasigna (nilotinib)

Snippet

Sponsor: The University of Hong Kong | Conditions: Leukemia, Myelogenous, Chronic Phase | Status: UNKNOWN